Table 2 Response to treatment

From: A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer

Response

Number (n=42)

%

Confirmed response

23

60

CR

2

5

PR

21

55

SD

6

14

PD

7

17

Not assessable

4

10

  1. CR=complete response; PR=partial response; SD=stable disease and PD= progressive disease.
Back to article page